Malhotra A, Grunstein RR, Fietze I, Weaver TE, Redline S, Azarbarzin A, et al
Throughout the first week and beyond, Troy Watson provides continuous support, offering tailored advice on nutrition, exercise, and lifestyle changes to complement the effects of semaglutide GLP-1
From JAMA Internal Medicine: This JAMA patient page covers #GLP1 weight-loss medications, focusing on food craving reduction, blood glucose control, dietary strategies, exercise for muscle retention, and lifestyle changes to prevent weight regain
The additive effects of combination treatment of GLP-1RAs and SGLT2 inhibitors on DKD are uncertain
Tirzepatide produces 21% body weight reduction compared to 18% for semaglutide at comparable doses, though individual responses vary widely